










































Targeting of GFP-Cre to the Mouse Cyp11a1 Locus Both Drives
Cre Recombinase Expression in Steroidogenic Cells and Permits
Generation of Cyp11a1 Knock Out Mice
Citation for published version:
O'Hara, L, York, JP, Zhang, P & Smith, LB 2014, 'Targeting of GFP-Cre to the Mouse Cyp11a1 Locus Both
Drives Cre Recombinase Expression in Steroidogenic Cells and Permits Generation of Cyp11a1 Knock Out
Mice' PLoS One, vol. 9, no. 1, pp. e84541. DOI: 10.1371/journal.pone.0084541
Digital Object Identifier (DOI):
10.1371/journal.pone.0084541
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright: © 2014 O'Hara et al. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Targeting of GFP-Cre to the Mouse Cyp11a1 Locus Both
Drives Cre Recombinase Expression in Steroidogenic
Cells and Permits Generation of Cyp11a1 Knock Out Mice
Laura O’Hara1, Jean Philippe York2, Pumin Zhang2, Lee B. Smith1*
1Medical Research Council Centre for Reproductive Health, University of Edinburgh, Edinburgh, United Kingdom, 2Department of Molecular Physiology and Biophysics,
Baylor College of Medicine, Houston, Texas, United States of America
Abstract
To permit conditional gene targeting of floxed alleles in steroidogenic cell-types we have generated a transgenic mouse line
that expresses Cre Recombinase under the regulation of the endogenous Cytochrome P450 side chain cleavage enzyme
(Cyp11a1) promoter. Mice Carrying the Cyp11a1-GC (GFP-Cre) allele express Cre Recombinase in fetal adrenal and testis, and
adrenal cortex, testicular Leydig cells (and a small proportion of Sertoli cells), theca cells of the ovary, and the hindbrain in
postnatal life. Circulating testosterone concentration is unchanged in Cyp11+/GC males, suggesting steroidogenesis is
unaffected by loss of one allele of Cyp11a1, mice are grossly normal, and Cre Recombinase functions to recombine floxed
alleles of both a YFP reporter gene and the Androgen Receptor (AR) in steroidogenic cells of the testis, ovary, adrenal and
hindbrain. Additionally, when bred to homozygosity (Cyp11a1GC/GC), knock-in of GFP-Cre to the endogenous Cyp11a1 locus
results in a novel mouse model lacking endogenous Cyp11a1 (P450-SCC) function. This unique dual-purpose model has
utility both for those wishing to conditionally target genes within steroidogenic cell types and for studies requiring mice
lacking endogenous steroid hormone production.
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Introduction
Mouse models of conditional gene ablation using the Cre/loxP
system [1] have led to a deeper understanding of cell-specific
gene function, as well as novel models of development and
disease. The power of this system relies upon temporal or spatial
localisation of Cre Recombinase expression, with different
promoters able to drive Cre Recombinase expression in
restricted cell lineages or time-points. Over 500 Cre expressing
mouse lines are now available [2], making the choice of which
Cre line to use target a particular cell-type ever more important.
As such, a measure of the utility of any Cre Recombinase line is
dependent upon validation of its sites and timing of expression
[3].
Steroidogenic enzymes are produced by the Leydig cells of the
testis in the male, the theca cells of the ovary in the female, the
trophoblastic giant cells of the placenta and the adrenocortical
cells of the adrenal gland in both sexes [4]. Steroidogenic enzyme
expression has also been detected in the brain in several species
[5,6]. Cytochrome P450 side chain cleavage (P450-SCC), the
product of Cyp11a1 gene expression, plays a major role in the
control of steroidogenesis by mediating the conversion of
cholesterol to pregnenolone. As the first step in the synthesis of
all steroidogenic enzymes it is therefore common to all steroido-
genic cells. Consequently transgenic disruption of the Cyp11a1
locus results in mice that fail to synthesise steroids, and die shortly
after birth due to adrenal insufficiency, unless rescued with
exogenous steroids [7]. Cyp11a1 knockout mice display a variety of
aberrant phenotypes associated with various steroid hormone
deficiency syndromes and as such provide an excellent model for
investigation of steroid function [8].
Additionally, the requirement for Cyp11a1 expression in all
steroidogenic cells makes this locus an ideal candidate to drive Cre
recombinase expression to target recombination of floxed genes
specifically within these cells. Indeed two Cyp11a1-Cre lines have
previously been generated, one using a 4.4 Kb promoter fragment
of human CYP11A1 to drive Cre expression in the steroidogenic
cells and brain [9], and one using a BAC transgenic approach to
place Cre Recombinase under the control of an extended
sequence of the mouse Cyp11a1 promoter [10]. As our primary
interest is in the process of steroidogenesis we have taken an
alternative approach, targeting a GFP-Cre transgene into the
endogenous mouse Cyp11a1 locus. In contrast to the published
Cyp11a1-Cre mouse lines, this approach permits generation of
Cyp11a1 knockout mice, in addition to driving Cre Recombinase
expression in steroidogenic cells of the testis, ovary, adrenal and
hindbrain.
In this paper we describe the functional characterisation of this
novel model, highlighting its utility both for targeting Cre
Recombinase to steroidogenic cell-types and for generation of
mice lacking Cyp11a1.
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Figure 1. Generation of the Cyp11a1-GC line and production of mice lacking Cyp11a1. A 7.9 Kb genomic fragment of Cyp11a1 (containing
the first 4 exons) was gap repaired onto pDTA.4B from a BAC clone obtained from Sanger Institute. GFP::Cre plus the neomycin resistant gene
(flanked by Frt sites; also confers kanamycin resistance in bacteria) was inserted into the first ATG site via homologous recombination. Electroporation
of ES cells was followed by neomycin selection and genotyping to confirm recombination of the Cyp11a1-GC construct into the endogenous
Cyp11a1 locus (1a) Note, EcoRV recognition sites, Southern blot probe binding sites and PCR genotyping primer binding sites are shown. Asterisks
identify base-pairs from chromosome 9 in build 37.1 of the mouse ensembl database (www.ensembl.org). Correctly targeted clones were identified
by Southern blotting using 59 and 39 probes following digest of Genomic DNA with EcoRV (1b). Average testis weight (1c), seminal vesicle weight (1d)
and AGD (1e) do not differ between Cyp11a1+/+ and Cyp11a1+/GC mice. PCR genotyping of offspring from inter-crossed Cyp11a1+/GC mice identified
inheritance of the Cyp11a1-GC allele (296 bp; 376 bp=WT) (1f) RT-PCR analysis on adrenals taken from these pups demonstrated expression of Cre
Recombinase (400 bp) (1 g), and absence of endogenous Cyp11a1 transcript (1 h), as predicted. Together these data confirmed the utility of the line
for production of mice lacking Cyp11a1. M =marker; Neg= no template control.
doi:10.1371/journal.pone.0084541.g001
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Materials and Methods
Generation of Cyp11a1-GC Transgenic Mice
A 7.9 kb genomic fragment of Cyp11a1 (containing the first 4
exons) was gap repaired by homologous recombination onto
pDTA.4B from a BAC clone obtained from Sanger Institute. A
targeting vector containing GFP-Cre cassette (GC) and FRT site
flanked Kanamycin/neomycin selection cassette was used to
disrupt the exon containing the ATG translation start-site. The
construct was electroporated into 129P2/OlaHsd derived
E14Tg2a.4 embryonic stem (ES) cells [11]. Correctly targeted
ES cells were injected into recipient blastocysts. The resulting
chimeric animals were crossed to C57BL/6 mice. Genomic DNA
isolated from wild-type and heterozygous mice were digested
with EcoRV, separated in 0.8% agarose gel, transferred to
charged nylon membrane, and hybridized with 32P-labeled
probes designed to be located either upstream (59) or down-
stream (39) of the transgene insertion site. Due to EcoRV sites
present in the transgene, a band of 14 kb could be seen in wild-
type mice with both 59 and 39 probes. Heterozygotes showed a
band of 14 kb and also 10.5 kb for the 59 or 6.5 kb for the 39
probe.
Production of Cyp11a1-KO, Cyp11a1-GC ARKO and
Cyp11a1-GC EFYP reporter mice
To generate Cyp11a1 knockout mice, Cyp11a1+/GC male and
female were inter-crossed. For lineage tracing of Cre Recombinase
function, Cyp11a1+/GC male mice were bred to R26R-EFYP
homozygous females [12]. To ablate androgen receptor from
steroidogenic cells, male Cyp11a1+/GC mice were mated to
C57BL/6J female homozygous ARfl/fl mice [13]. The Cyp11a1+/
GC:ARfl/y male offspring from these matings were termed
‘Cyp11a1-ARKO’, whereas the Cyp11a1+/+:ARfl/y littermates
were used as controls, termed ‘control’. Sex and genotype ratios
were identified at the expected Mendelian ratios across all
matings. All mice were bred under standard conditions of care
and use under licensed approval from the UK Home Office (PPL:
60/4200).
Recovery of tissues
Adult mice were culled at post-natal day (d) 100 by inhalation
of carbon dioxide and subsequent cervical dislocation. Body
weight and anogenital distance were measured and mice were
examined for any gross abnormalities of the reproductive system.
Testes and SV were removed and weighed from male mice.
Ovaries were removed from females. Tissues were fixed in
Bouin’s fixative (Clin-Tech, Guildford, UK) for 6 h. Bouin’s-
fixed tissues were processed and embedded in paraffin wax, and
5-mm sections were used for histological analysis as reported
previously [14]. Sections of testis were stained with hematoxylin
and eosin using standard protocols and examined for histological
abnormalities.
PCR genotyping
PCR genotyping for inheritance of the Cyp11a1-GC allele was
carried out as previously described http://jaxmice.jax.org/
protocolsdb/f?p= 116:2:3453436993967916::NO:2:P2_MASTER
_PROTOCOL_ID,P2_JRS_CODE:3815,010988 using primers
P450-F: 59 GAGCTGCCTGCCAGTGTTTG 39; P450-R: 59
GGACCTAGGACTGCTAGTAG 39; and GFP-R: 59 GTCC-
AGCTCGACCAGGATGG 39. PCR amplification products
were resolved using a QiaXcel capillary system (Qiagen, UK).
Determination of genomic ablation of AR
Frozen tissues were genotyped for genomic ablation of AR as
previously described [15]. PCR amplification products were
resolved using a QiaXcel capillary system (Qiagen, UK). An
amplicon of 1142 bp indicated presence of a floxed AR whilst an
amplicon of 612 bp indicated recombination between loxP sites
and deletion of AR exon 2.
RNA extraction and reverse transcription
RNA was isolated from frozen adrenal glands collected from
e16.5 to d0 offspring of Cyp11a1+/GC x Cyp11a1+/GC matings
using the RNeasy Mini extraction kit with RNase-free DNase on-
column digestion (Qiagen, Crawley, UK) according to the
manufacturer’s instructions. RNA was quantified using a Nano-
Drop 1000 spectrophotometer (Thermo Fisher Scientific, Wal-
tham, MA, USA). cDNA was prepared using the SuperScriptH
VILOTM cDNA Synthesis Kit (Life Technologies) according to
manufacturer’s instructions.
RT-PCR validation of Cre Recombinase gene expression
RT-PCR was performed for Cre on adrenal cDNA using
primers – forward: GATCGCTGCCAGGATATACG, reverse:
AGGCCAGGTATCTCTGACCA, synthesised by Eurofins
MWG Operon. PCR amplification products were resolved using
a QiaXcel capillary system (Qiagen, UK). An amplicon of 400 bp
indicated presence of Cre transcript.
Quantitative analysis of Cyp11a1 gene expression
Quantitative RT-PCR was performed for Cyp11a1 on adrenal
cDNA using primers – forward: AAGTATGGCCCCATTTA-
CAGG, reverse: TGGGGTCCACGATGTAAACT, synthesised
by Eurofins MWG Operon and probe 104 from the Roche Mouse
Universal Probe library (Roche, Welwyn, UK). Assays were
carried out using the ABI Prism 7900 Sequence Detection System
(Applied Biosystems). The expression of each gene was related to
an internal housekeeping gene assay for Actb (Roche, Welwyn,
UK).
Fluorescence microscopy
Freshly dissected organs were visualised with a Leica MZFLIII
microscope and an epifluorescent YFP filter. Photographs were
taken with a Photometrics CoolSNAP camera and PMCapture
Pro 6.0 software.
Histochemical Analysis
Double immunofluorescent staining for YFP and 3bHSD was
performed on Cyp11a1-GC:EYFP and littermate controls and
single immunohistochemical staining for AR was performed on
Cyp11a1-Cre ARKO mice and littermate controls.
YFP/3bHSD immunofluorescence was performed based on a
double immunofluorescence protocol described previously [15].
Sections were deparaffinized and rehydrated, and high-pressure
antigen retrieval was performed in 0.01M pH 6 citrate buffer for
5 minutes. Endogenous peroxidase was blocked using 3%
hydrogen peroxide in methanol and non-specific antibody binding
sites were blocked with normal chicken serum (NChS)/TBS/BSA.
Sections were incubated overnight at 4uC with rabbit anti-GFP/
YFP (Abcam ab6556) then YFP immunostaining was detected
using chicken anti-rabbit peroxidase (Santa Cruz sc-2963) diluted
in NChS/TBS/BSA incubated for one hour at room temperature,
then fluorescein Tyramide Signal Amplification system (‘TSATM’,
Perkin Elmer) to manufacturer’s instructions for 10 minutes at
room temperature. Antigen retrieval was then repeated and the
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same slides stained using goat anti-3bHSD antibody (Santa Cruz
sc-30820) overnight at 4uC and detected with chicken anti-goat
peroxidase (Santa Cruz sc-2953) diluted in NChS/TBS/BSA
incubated for one hour at room temperature and TSA of a
different colour to distinguish from the first antibody detection.
Slides were counterstained with Sytox Green (Sigma, UK,
#P4170), mounted with PermaFluor mounting medium (Thermo
Figure 2. Expression of YFP in tissues from Cyp11a1+/GC:R26-EYFP mice. Bright field and epifluorescence localisation of YFP expression in
e17.5 embryos and placenta. YFP expression is undetectable in the placenta (2a). Consistent with predicted expression pattern of Cyp11a1, YFP
expression is detectable in the fetal testis and adrenal, but absent from the fetal ovary (2b). Epifluorescence microscopy in adulthood confirms
expression of YFP in the testis, ovary, adrenal of both sexes and cerebellum (2c). Immunofluorescent localisation of YFP using an anti-YFP antibody on
tissues sections demonstrates YFP expression localised to testicular Leydig cells (arrowhead), and a small number of Sertoli cells (arrow) (2d)
Bar = 100 mm. In the ovary, YFP expression is restricted to theca cells (2e) Bar = 100 mm. In the adrenal YFP is localised to the adrenal cortex (2f)
Bar = 100 mm.
doi:10.1371/journal.pone.0084541.g002
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Scientific, UK). Images were captured using a LSM 710 confocal
microscope (Zeiss) with Zen software.
Automated AR immunostaining was performed on a Bond-max
machine (Leica, UK) using rabbit anti-AR (Abcam ab74272) at
1:250 concentration and a Polymer Refine Detection kit according
to the manufacturer’s instructions. Antigen retrieval was per-
formed with Leica Bond ER2 buffer. Slides were counterstained
with hematoxylin, dehydrated, and mounted with Pertex (Histo-
lab, Gothenburg, Sweden); images were captured using a Provis
Figure 3. Characterisation of Cyp11a1+/GC:ARKO mice. PCR interrogation of genomic DNA from tissues of male e17.5 embryos demonstrates
recombination of the floxed AR allele in testis and adrenal, but not brain or placenta. Amplification from total ARKO mouse included for comparison
(3a). PCR amplification on adult tissues confirms ablation of AR form a proportion of testis and adrenal cells, and in addition, confirms ablation of AR
from hindbrain (HB), but not forebrain (FB) or midbrain (MB) (3b). Immunohistochemical localisation of AR on adult adrenal and testis sections
confirms absence of AR expression from the adrenal cortex of Cyp11a1-ARKO mice, and from a proportion of testicular Leydig cells (arrow) although a
proportion of Leydig cells retain AR expression (arrowhead) (3c) Bar = 20 mm. Double staining for 3bHSD and AR identifies interstitial Leydig cells (3d)
allowing quantification of AR ablation in Leydig cells of the Cyp11a1-ARKO (3e).
doi:10.1371/journal.pone.0084541.g003
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AX70 microscope (Olympus, Southend-on-Sea, UK) equipped a
Axiocam HRc (Zeiss, Welwyn Garden City, UK).
A minimum of five mice of each genotype was used and sections
from transgenic and control littermates were processed in parallel
on the same slide, on at least two separate occasions. A no-primary
control was included to ensure that any staining observed was
specific.
Quantification of AR ablation in Leydig cells
AR in Leydig cell was quantified using a method based on a
previously published protocol [16]. Briefly AR ablation was
quantified in testis sections immuno-stained for 3bHSD and AR
from three Cyp11a1-ARKO and two control animals at d100.
Sections were analysed using Image-Pro Plus 6.2 software with a
Stereology 5.0 plug-in (Media Cybernetics U.K., Berkshire, UK)
with the663 objective on a Leitz DBRB microscope fitted with a
Prior Pro-Scan automatic stage (Prior Scientific Instruments Ltd.,
Cambridge, UK). The Count (NV) setting was used to count all
3bHSD-positive cells staining either positive or negative for AR.
Results
Generation of Cyp11a1-GC mice
A 7.9 Kb genomic fragment of Cyp11a1 (containing the first 4
exons) was gap repaired onto pDTA.4B from a BAC clone
obtained from the Sanger Institute (Cambridge, UK). GFP::Cre
plus a neomycin resistant gene (also confers kanamycin resistance
in bacteria) flanked by Frt sites was inserted into the first ATG site
via homologous recombination as previously described [11]. The
targeted allele was named Cyp11a1-GC (Figure 1a). The construct
was electroporated into 129P2/OlaHsd derived E14Tg2a.4
embryonic stem (ES) cells [11]. Correctly targeted ES cells were
identified through Southern blotting following EcoRV digest of ES
cell DNA (Figure 1b), and were injected into recipient blastocysts.
The resulting chimeric animals were crossed to C57BL/6 mice to
generate a transgenic line containing the Cyp11a1-GC allele
(Cyp11a1+/GC).
Production of Cyp11a1 Knock Out mice
Cyp11a1+/GC mice were normal in appearance and healthy. No
significant difference in anogenital distance (AGD), testis weight or
seminal vesicle (SV) weight between Cyp11a1+/GC and Cyp11a1+/+
males was noted (Figure 1c to e), demonstrating androgen
production was unaffected. Male and female Cyp11a1+/GC mice
were inter-crossed to generate Cyp11a1GC/GC animals, and
genotyped confirmed by PCR (Figure 1f). RT-PCR analysis of
adrenal tissue demonstrated production of Cre recombinase by
both Cyp11a1+/GC and Cyp11a1GC/GC mice (Figure 1g) and
quantitative RT-PCR for Cyp11a1 confirmed that Cyp11a1GC/GC
mice lack endogenous Cyp11a1 (Figure 1h), confirming the utility
of this line for generation of Cyp11a1-null mice.
Expression of GFP and Cre Recombinase
Although the Cyp11a1-GC allele contains GFP, no GFP
expression could be detected in tissues when visualised under
fluorescence microscopy, or via immunohistochemistry, at any age
examined (data not shown). To establish the utility of the Cyp11a1-
GC allele as a Cre Recombinase expressing line Cyp11a1+/GC males
were bred to homozygous R26R-EYFP females [12]. Cre-
mediated recombination removes an upstream stop codon,
permitting persistent expression of YFP in cells which acts as a
lineage tracer for sites of functional Cre Recombinase expression.
Examination of e17.5 embryos under fluorescence microscopy
revealed YFP expression restricted to the fetal testis and adrenal (of
both sexes) (Figure 2 a, b). Consistent with established sites of
expression of Cyp11a1 in the embryo, YFP expression was not
detected in the fetal ovary or placenta. In a divergence from the
reported expression pattern of Cre Recombinase under the control
of 4.4 Kb of the human Cyp11a1 promoter, YFP expression was
absent from the fetal brain when examined by fluorescence
microscopy. Furthermore, as predicted, no expression was
observed in other tissues of the body, including pituitary, kidney,
heart, liver, seminal vesicles and pancreas (figure 2a and data not
shown).
YFP expression was also absent from the ovary when examined
at postnatal day 12 (d12) whilst YFP expression continued to be
observed in the testis and adrenal (data not shown). In adulthood,
YFP expression was again restricted to steroidogenic tissues, not
only the testis and adrenal (both sexes), but also in the ovary and
cerebellum (Figure 2c). Double immunofluorescent detection of
YFP on tissue sections combined with 3bHSD to mark steroido-
genic cells localised YFP expression to a subset of Leydig cells of
the testis (and occasional Sertoli cells), theca cells of the ovary and
Table 1. Overview of Cyp11a1-Cre Recombinase lines.
Mouse line SCC-Cre [9] Cyp11a1-iCre [10] Cyp11a1-GC
Nature of transgene
4.4 Kb – human
promoter (pronuclear)




Prenatal Placenta 2 ? 2
Prenatal Adrenal +++ +++ +++
Prenatal Testis +++ +++ +++
Prenatal Ovary + 2 2
Prenatal Brain ++ ? 2
Postnatal Adrenal +++ +++ +++
Postnatal Testis +++ +++ +++
Postnatal Ovary +++ +++ +++
Postnatal Brain ++ ? ++
Cyp11a1-KO? No No Yes
(+= expressed; 2=not expressed; ? = expression not reported).
doi:10.1371/journal.pone.0084541.t001
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the cortex of the adrenal, consistent with the known expression
pattern of Cyp11a1 (P450-SCC) (Figure 2 d–f).
Validation using a second floxed line
To determine the functional ability of the Cyp11a1-GC allele to
excise an independent floxed gene, located at a distinct
chromosomal locus in vivo, Cyp11a1+/GC male mice were bred
with females carrying a floxed allele of the X-linked Androgen
Receptor (ARfl/fl) [13]. Male pups were examined. Recombination
of AR genomic DNA was interrogated at e17.5. Consistent with
observations of recombination at the R26R-EFYP locus, recom-
bination was detected in a proportion of testis cells and adrenal
cells, but completely absent from the placenta and brain
(Figure 3a). In adulthood, recombination was detected in a small
proportion of cells of the testis and the majority of the adrenal,
along with recombination in the hindbrain (but not the forebrain
or midbrain) (Figure 3b). Immunohistochemical localisation of AR
in tissues sections from adult adrenals and testes showed
recombination of AR throughout the adrenal cortex, and in a
proportion of testicular Leydig cells (Figure 3c), again consistent
with the data derived from recombination of the R26R-EYFP
locus, and the normal cellular localisation of Cyp11a1 (P450-SCC).
AR/3bHSD double staining (Figure 3d) and stereological cell
counting quantified that 96% of 3bHSD Leydig cells in littermate
control testes express AR compared to 76% in Cyp11a1-ARKO
testes (Figure 3e).
Discussion
We describe the construction and functional validation of a
novel dual-purpose mouse line of utility for the study of
steroidogenesis and steroidogenic cell types. Targeting of Cre
Recombinase into the mouse endogenous Cyp11a1 locus, permits
both the generation of Cyp11a1 knockout mice and a novel Cre
Recombinase line targeting steroidogenic cell-types. This line has
been deposited with the Jackson Laboratory, (Maine, USA) stock
number 010988.
Gene expression and functional recombination by Cre Re-
combinase is restricted to the developing cortex of the fetal adrenal
(both sexes) and Leydig cells of the fetal testis in prenatal life.
Postnatally, in addition to the adrenal and Leydig cells (and a small
proportion of Sertoli cells) in the testis, Cre Recombinase-
mediated recombination is detectable in theca cells of the ovary,
and the hindbrain. Taken together, the Cyp11a1-GC line provides
a novel Cre Recombinase model with utility for targeting cells
of steroidogenic lineages. Despite the presence of GFP in the
transgene, no GFP expression was noted in Cyp11a1-GC
tissues by either epifluorescence or immunofluorescence and a
Cyp11a1+/GC:R26-EYFP line was required to localise Cre recom-
bination. This may be because low levels of the transgene do not
produce enough GFP to be detectable by immunofluorescence,
but the same level of Cre is enough to result in recombination in a
proportion of cells. This requires further investigation but
nevertheless does not appear to detract from the function activity
of Cre Recombinase and the utility of the line as such.
Several Cre Recombinase lines now target the steroidogenic
lineage [9,10,17], each with overlapping but not identical
expression patterns (Table 1), thus providing a level of choice
and refinement when targeting floxed genes in steroidogenic cells.
Two other published models utilise a Cyp11a1 promoter as a driver
of Cre Recombinase expression. The first exploits 4.4 Kb of the
human CYP11A1 promoter in a minigene construct introduced by
pronuclear injection (SCC-Cre) [17]. Whilst the resultant expres-
sion of Cre Recombinase (as defined by lineage tracing) closely
mimics that of the Cyp11a1-GC mouse, there are several distinct
differences. Expression of SCC-Cre is detected albeit weakly in the
fetal ovary (endogenous Cyp11a1 is not found in the fetal ovary),
and in distinct regions of the brain in both fetal and adult life,
conversely no fetal ovary expression is detected in the Cyp11a1-
GC line, and expression in the brain is restricted to postnatal life,
and in the hindbrain, a localisation distinct to that of expression in
the SCC-Cre brain [17,18].
A second line, Cyp11a1iCre utilised a mouse BAC transgenic
approach to drive Cre recombinase expression utilising an
extensive region of the mouse promoter (again introduced by
pronuclear injection) [10]. Lineage tracing of the Cre Recombi-
nase expression closely mimics that of Cyp11a1-GC allele,
suggesting that inclusion of a more extensive promoter region,
and perhaps from mouse rather than human, provides a more
faithful representation of endogenous gene expression. Neverthe-
less, all three lines have utility for targeting steroidogenic cell-types.
The unique advantage of the Cyp11a1-GC line over other
steroidogenic Cre Recombinase lines is the ability to also generate
Cyp11a1 knock out mice. Ablation of Cyp11a1 in the original
Cyp11a1 knockout mouse has provided important insights into
steroid hormone production and action, providing insight into
human conditions of steroid hormone deficiency [19]. The dual
nature of the Cyp11a1-GC allele is the ability not only to ablate
P450-SCC function, but also to exploit the knock-in of Cre
Recombinase to simultaneously target other floxed genes in
steroidogenic cells of the Cyp11a1 knockout mouse, and/or to
utilise lineage tracing to track the fate of these cells. Both of these
approaches will enhance our understanding of the control of
steroidogenesis.
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